Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahmood Wahed

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Journal of Gastroenterology & Hepatology|April 7, 2007
Novel substratesMahmood Wahed, Michael Geoghegan, Jeremy Powell-Tuck
Expert Review of Gastroenterology & Hepatology|November 26, 2009
Management of stress in inflammatory bowel disease: a therapeutic option?James R Goodhand, Mahmood Wahed, David S Rampton
Inflammatory Bowel Diseases|September 24, 2009
Does psychological counseling alter the natural history of inflammatory bowel disease?Mahmood Wahed, Meg Corser, James R Goodhand, et al.
European Journal of Gastroenterology & Hepatology|October 30, 2010
Tobacco dependence and awareness of health risks of smoking in patients with inflammatory bowel diseaseMahmood Wahed, James R Goodhand, Oliver West, et al.
European Journal of Gastroenterology & Hepatology|August 23, 2011
Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practiceAsma Khalil, James R Goodhand, Mahmood Wahed, et al.
Journal of Crohn'S & Colitis|April 30, 2013
Oral tacrolimus as maintenance therapy for refractory ulcerative colitis--an analysis of outcomes in two London tertiary centresJonathan Landy, Mahmood Wahed, Simon T C Peake, et al.
Frontline Gastroenterology|April 14, 2023
Development of a specialist ileoanal pouch surgery pathway: a multidisciplinary patient-centred approachValerio Celentano, Henna Rafique, Melanie Jerome, et al.
Inflammatory Bowel Diseases|May 24, 2011
Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel diseaseJames R Goodhand, Nikolasos Kamperidis, Arati Rao, et al.
Frontline Gastroenterology|September 2, 2022
Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumabCharles Miller, Hanson Kwok, Paul Harrow, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Gastroenterology & Hepatology|April 7, 2007
Novel substratesMahmood Wahed, Michael Geoghegan, Jeremy Powell-Tuck
Expert Review of Gastroenterology & Hepatology|November 26, 2009
Management of stress in inflammatory bowel disease: a therapeutic option?James R Goodhand, Mahmood Wahed, David S Rampton
Inflammatory Bowel Diseases|September 24, 2009
Does psychological counseling alter the natural history of inflammatory bowel disease?Mahmood Wahed, Meg Corser, James R Goodhand, et al.
European Journal of Gastroenterology & Hepatology|October 30, 2010
Tobacco dependence and awareness of health risks of smoking in patients with inflammatory bowel diseaseMahmood Wahed, James R Goodhand, Oliver West, et al.
European Journal of Gastroenterology & Hepatology|August 23, 2011
Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practiceAsma Khalil, James R Goodhand, Mahmood Wahed, et al.
Journal of Crohn'S & Colitis|April 30, 2013
Oral tacrolimus as maintenance therapy for refractory ulcerative colitis--an analysis of outcomes in two London tertiary centresJonathan Landy, Mahmood Wahed, Simon T C Peake, et al.
Frontline Gastroenterology|April 14, 2023
Development of a specialist ileoanal pouch surgery pathway: a multidisciplinary patient-centred approachValerio Celentano, Henna Rafique, Melanie Jerome, et al.
Inflammatory Bowel Diseases|May 24, 2011
Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel diseaseJames R Goodhand, Nikolasos Kamperidis, Arati Rao, et al.
Frontline Gastroenterology|September 2, 2022
Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumabCharles Miller, Hanson Kwok, Paul Harrow, et al.
Pageof 1